Innovacell (TSE:504A) Revenue: 円0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:504A Innovacell Inc TSE:504A
10 GF Score
Price 円583.00
View Full Analysis

What is Innovacell Revenue?

Innovacell TSE:504A +7.56% 10 Revenue is 円0.00 Mil as of Jun. 2026. GuruFocus rates TSE:504A with a GF Score™ of 10/100.

Innovacell's revenue for the three months ended in Jun. 2026 was 円0.00 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was 円0.00 Mil. Innovacell's Revenue per Share for the three months ended in Jun. 2026 was 円0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was 円0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

Innovacell  (TSE:504A) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Innovacell Revenue Related Terms

Innovacell Revenue Historical Data

* Premium members only.

The historical data trend for Innovacell's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovacell Revenue Chart

Innovacell Annual Data
Trend Dec23 Dec24 Dec25
Revenue
0.00 0.00 0.00

Innovacell Quarterly Data
Dec23 Dec24 Sep25 Dec25 Mar26 Jun26
Revenue Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

TSE:504A vs VRTX, REGN, MRNA: Revenue Comparison

For the Biotechnology subindustry, Innovacell's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovacell Revenue vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innovacell's Revenue distribution charts can be found below:

* The bar in red indicates where Innovacell's Revenue falls into.


TSE:504A
10GF Score
Innovacell Inc TSE:504A
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innovacell Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of 円0.00 Mil mean?
Innovacell (TSE:504A) has a Revenue of 円0.00 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Innovacell and its competitors.
Is Innovacell's Revenue too high?
Innovacell's current Revenue is 円0.00 Mil. Overall, Innovacell has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Innovacell's Revenue compare to VRTX and REGN?
Innovacell's Revenue of 円0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Biotechnology company?
A good Revenue depends on the Biotechnology industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Innovacell and its competitors. Innovacell's current Revenue is 円0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovacell stock overvalued right now?
Innovacell (TSE:504A) has a current Revenue of 円0.00 Mil. The current Revenue is 円0.00 Mil. Innovacell's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Innovacell (TSE:504A), the current Revenue is 円0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovacell Business Description

Address 3-5-11 Kamiosaki, Meguro Villa Garden, 5th floor, Shinagawa-ku, Tokyo, JPN, 141-0021
Innovacell Inc is engaged in the development, manufacturing, and sale of regenerative medicine products for the treatment of conditions including fecal and urinary incontinence. Its activities include researching potential therapeutic candidates, developing formulations, and commercializing products in the markets. The company is working on the development and commercialization of the following three cell therapy pipelines targeting incontinence (fecal and urinary incontinence): ICEF15, ICEF16, and ICES13.
10GF Score

Get the complete analysis for TSE:504A

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円583.00
Price